Literature DB >> 16894595

Linkage disequilibrium, haplotype and association studies of a chromosome 4 GABA receptor gene cluster: candidate gene variants for addictions.

Tomas Drgon1, Claudio D'Addario, George R Uhl.   

Abstract

Strong genetic contributions to individual differences in vulnerability to addictions are well supported by classical genetic studies. Linkage and association genome scans for addiction vulnerability have provided converging evidence for several chromosomal regions which are likely to harbor allelic variants that contribute to such vulnerability. We and others have delineated a candidate addiction-associated chromosome 4p12 "rSA3" region based on convergent data from association genome scanning studies in polysubstance abusers [Uhl et al. (2001); Am J Hum Genet 69(6):1290-1300], linkage-based studies in alcoholism [Long et al. (1998); Am J Med Genet 81(3):216-221; Reich et al. (1998); Am J Med Genet 81(3):207-215] and association-based studies for alcoholism and association-based studies for individual differences in electroencephalographic (EEG) spectral power phenotypes [Porjesz et al. (2002); Proc Natl Acad Sci USA 99(6):3729-3733; Edenberg et al. (2004); Am J Hum Genet 74(4):705-714]. The rSA3 region contains interesting candidate genes that encode the alpha 2, alpha 4, beta 1, and gamma 1 receptor subunits for the principal brain inhibitory neurotransmitter, gamma-aminobutyric acid (GABA) [Covault et al. (2004); Am J Med Genet Part B 129B:104-109; Edenberg et al. (2004); Am J Hum Genet 74(4):705-714; Lappalainen et al. (2005); Alcohol Clin Exp Res 29(4):493-498]. We now report assessment of single nucleotide polymorphism (SNP) genotypes in this region in three samples of substance abusers and controls. These results delineate the haplotypes and patterns of linkage disequilibrium in this region, focus attention of the GABRA2 gene and identify modest associations between GABRA2 genotypes and addiction phenotypes. These results are consistent with modest roles for GABRA2 variants in addiction vulnerabilities. (c) 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16894595      PMCID: PMC3922197          DOI: 10.1002/ajmg.b.30349

Source DB:  PubMed          Journal:  Am J Med Genet B Neuropsychiatr Genet        ISSN: 1552-4841            Impact factor:   3.568


  31 in total

1.  Novel tests for marker-disease association using the Collaborative Study on the Genetics of Alcoholism data.

Authors:  D Nielsen; D Zaykin
Journal:  Genet Epidemiol       Date:  1999       Impact factor: 2.135

Review 2.  Molecular genetic underpinnings of human substance abuse vulnerability: likely contributions to understanding addiction as a mnemonic process.

Authors:  George R Uhl
Journal:  Neuropharmacology       Date:  2004       Impact factor: 5.250

3.  Association between alcoholism and gamma-amino butyric acid alpha2 receptor subtype in a Russian population.

Authors:  Jaakko Lappalainen; Evgeny Krupitsky; Mikhail Remizov; Sofia Pchelina; Anastaisa Taraskina; Edwin Zvartau; Lucia K Somberg; Jonathan Covault; Henry R Kranzler; John H Krystal; Joel Gelernter
Journal:  Alcohol Clin Exp Res       Date:  2005-04       Impact factor: 3.455

4.  Cigarette smoking and alcohol use in Finland and Sweden: a cross-national twin study.

Authors:  J Kaprio; N Hammar; M Koskenvuo; B Floderus-Myrhed; H Langinvainio; S Sarna
Journal:  Int J Epidemiol       Date:  1982-12       Impact factor: 7.196

5.  Polysubstance abuse-vulnerability genes: genome scans for association, using 1,004 subjects and 1,494 single-nucleotide polymorphisms.

Authors:  G R Uhl; Q R Liu; D Walther; J Hess; D Naiman
Journal:  Am J Hum Genet       Date:  2001-11-06       Impact factor: 11.025

6.  Linkage disequilibrium between the beta frequency of the human EEG and a GABAA receptor gene locus.

Authors:  Bernice Porjesz; Laura Almasy; Howard J Edenberg; Kongming Wang; David B Chorlian; Tatiana Foroud; Alison Goate; John P Rice; Sean J O'Connor; John Rohrbaugh; Samuel Kuperman; Lance O Bauer; Raymond R Crowe; Marc A Schuckit; Victor Hesselbrock; P Michael Conneally; Jay A Tischfield; Ting-Kai Li; Theodore Reich; Henri Begleiter
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-12       Impact factor: 11.205

7.  ADH4 gene variation is associated with alcohol dependence and drug dependence in European Americans: results from HWD tests and case-control association studies.

Authors:  Xingguang Luo; Henry R Kranzler; Lingjun Zuo; Jaakko Lappalainen; Bao-zhu Yang; Joel Gelernter
Journal:  Neuropsychopharmacology       Date:  2006-05       Impact factor: 7.853

8.  The blocking effect of gamma-aminobutyric acid (GABA) and the action of related compounds on single nerve cells.

Authors:  C EDWARDS; S W KUFFLER
Journal:  J Neurochem       Date:  1959-04       Impact factor: 5.372

9.  Allelic and haplotypic association of GABRA2 with alcohol dependence.

Authors:  Jonathan Covault; Joel Gelernter; Victor Hesselbrock; Maggie Nellissery; Henry R Kranzler
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2004-08-15       Impact factor: 3.568

Review 10.  The role of GABAA receptors in mediating the effects of alcohol in the central nervous system.

Authors:  Martin Davies
Journal:  J Psychiatry Neurosci       Date:  2003-07       Impact factor: 6.186

View more
  41 in total

1.  α2-containing GABA(A) receptors: a requirement for midazolam-escalated aggression and social approach in mice.

Authors:  Emily L Newman; Kiersten S Smith; Aki Takahashi; Adam Chu; Lara S Hwa; Yang Chen; Joseph F DeBold; Uwe Rudolph; Klaus A Miczek
Journal:  Psychopharmacology (Berl)       Date:  2015-09-17       Impact factor: 4.530

2.  Examination of genetic variation in GABRA2 with conduct disorder and alcohol abuse and dependence in a longitudinal study.

Authors:  Whitney E Melroy; Sarah H Stephens; Joseph T Sakai; Helen M Kamens; Matthew B McQueen; Robin P Corley; Michael C Stallings; Christian J Hopfer; Kenneth S Krauter; Sandra A Brown; John K Hewitt; Marissa A Ehringer
Journal:  Behav Genet       Date:  2014-04-01       Impact factor: 2.805

3.  Interpopulation linkage disequilibrium patterns of GABRA2 and GABRG1 genes at the GABA cluster locus on human chromosome 4.

Authors:  Chupong Ittiwut; Jennifer Listman; Apiwat Mutirangura; Robert Malison; Jonathan Covault; Henry R Kranzler; Atapol Sughondhabirom; Nuntika Thavichachart; Joel Gelernter
Journal:  Genomics       Date:  2007-11-05       Impact factor: 5.736

Review 4.  GABA(A) receptors and their associated proteins: implications in the etiology and treatment of schizophrenia and related disorders.

Authors:  Erik I Charych; Feng Liu; Stephen J Moss; Nicholas J Brandon
Journal:  Neuropharmacology       Date:  2009-07-23       Impact factor: 5.250

Review 5.  New insights into the genetics of addiction.

Authors:  Ming D Li; Margit Burmeister
Journal:  Nat Rev Genet       Date:  2009-04       Impact factor: 53.242

6.  GABRG1 and GABRA2 as independent predictors for alcoholism in two populations.

Authors:  Mary-Anne Enoch; Colin A Hodgkinson; Qiaoping Yuan; Bernard Albaugh; Matti Virkkunen; David Goldman
Journal:  Neuropsychopharmacology       Date:  2008-09-24       Impact factor: 7.853

Review 7.  An Emerging Circuit Pharmacology of GABAA Receptors.

Authors:  Elif Engin; Rebecca S Benham; Uwe Rudolph
Journal:  Trends Pharmacol Sci       Date:  2018-06-11       Impact factor: 14.819

8.  Gamma-aminobutyric acid system genes--no evidence for a role in alcohol use and abuse in a community-based sample.

Authors:  Daniel E Irons; William G Iacono; William S Oetting; Robert M Kirkpatrick; Scott I Vrieze; Michael B Miller; Matt McGue
Journal:  Alcohol Clin Exp Res       Date:  2014-01-24       Impact factor: 3.455

Review 9.  Peter Riederer "70th birthday" neurobiological foundations of modern addiction treatment.

Authors:  Christian Jacob
Journal:  J Neural Transm (Vienna)       Date:  2012-08-19       Impact factor: 3.575

10.  The influence of GABRA2, childhood trauma, and their interaction on alcohol, heroin, and cocaine dependence.

Authors:  Mary-Anne Enoch; Colin A Hodgkinson; Qiaoping Yuan; Pei-Hong Shen; David Goldman; Alec Roy
Journal:  Biol Psychiatry       Date:  2010-01-01       Impact factor: 13.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.